Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Common Stock | Options Exercise | $177K | +9.25K | +2.6% | $19.17 | 365K | Jun 17, 2021 | Direct | F1 |
transaction | AXGN | Common Stock | Tax liability | -$184K | -8.78K | -2.41% | $20.92 | 356K | Jun 17, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Employee Stock Option (right to purchase) | Options Exercise | $0 | -9.25K | -100% | $0.00* | 0 | Jun 17, 2021 | Common Stock | 9.25K | $19.17 | Direct | F2 |
Id | Content |
---|---|
F1 | Of the 8,781 reported shares, 8,477 shares were swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule 16b-3. Additionally, 304 shares of common stock were surrendered to satisfy the reporting person's tax withholding liability. In total, the reporting person received 469 additional shares of common stock. |
F2 | All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on December 27, 2022 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. |